VVT Med Inc. (TSXV:VVTM)
0.1900
-0.0200 (-9.52%)
At close: Aug 31, 2026
VVT Med Revenue
VVT Med had revenue of $33.00K USD in the quarter ending June 30, 2026, with 135.71% growth. This brings the company's revenue in the last twelve months to $96.00K, down -11.93% year-over-year. In the year 2025, VVT Med had annual revenue of $89.00K, down -81.91%.
Revenue (ttm)
$96.00K
Revenue Growth
-11.93%
P/S Ratio
101.17
Revenue / Employee
n/a
Employees
n/a
Market Cap
13.79M CAD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 89.00K | -403.00K | -81.91% |
| Dec 31, 2024 | 492.00K | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 231.74K | -635.66K | -73.28% |
| Dec 31, 2019 | 867.39K | -418.27K | -32.53% |
| Dec 31, 2018 | 1.29M | -686.20K | -34.80% |
| Dec 31, 2017 | 1.97M | -1.06M | -34.99% |
| Dec 31, 2016 | 3.03M | -2.08M | -40.71% |
| Dec 31, 2015 | 5.12M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 24.92M |
| Perimeter Medical Imaging AI | 3.03M |
| Cheelcare | 1.91M |
| Conavi Medical | 845.00K |
| Theralase Technologies | 802.46K |
| Frequency Exchange | 647.43K |
| MedX Health | 569.79K |
| Ventripoint Diagnostics | 179.93K |